Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale - Lopes, R D; Alexander, J H; Al-Khatib, S M (Am Heart J, 2010)
, et al; ARISTOTLE Investigators.